Investing Ideas Browse All Stocks Markets

Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap - Simply Wall St

Advanced Filters

Largest U.S. Pharmaceuticals & Biotech Stocks by Market Cap

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

UPDATED Jul 23, 2026

Discover large cap U.S. Pharmaceuticals & Biotech companies that are on the NYSE and NASDAQ. These Pharmaceuticals & Biotech Companies are organised by Market Cap.

708 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
LLY	US$1,185.87	1.4%	47.2%	US$1.0t	US$1,270.37	41.8	16.5%	0.6%
JNJ	US$259.27	3.7%	52.9%	US$615.4b	US$270.59	29.7	9.8%	2.1%
ABBV	US$256.92	1.0%	34.6%	US$447.5b	US$266.89	126.3	27.3%	2.7%
MRK	US$130.48	2.2%	55.1%	US$314.8b	US$134.62	36.1	21.0%	2.6%
AMGN	US$371.50	1.4%	21.2%	US$200.5b	US$356.69	25.7	7.6%	2.7%
TMO	US$572.32	5.4%	20.5%	US$195.6b	US$599.73	31.1	11.0%	0.3%
GILD	US$130.86	-4.0%	15.6%	US$161.8b	US$157.56	17.6	20.2%	2.5%
PFE	US$25.01	-0.5%	-1.3%	US$141.5b	US$28.75	19.1	-1.7%	6.9%
DHR	US$192.50	-6.1%	-5.1%	US$125.9b	US$227.61	33.9	16.2%	0.8%
BMY	US$61.51	1.7%	25.7%	US$124.1b	US$62.96	17.3	-2.4%	4.1%
VRTX	US$473.09	-2.7%	0.2%	US$119.9b	US$554.91	27.7	13.0%	n/a
REGN	US$651.91	-4.0%	15.5%	US$66.3b	US$819.25	15.0	11.7%	0.6%
RVMD	US$188.75	5.3%	407.1%	US$38.9b	US$204.38	26.8	59.4%	n/a
NTRA	US$264.69	-1.9%	87.6%	US$37.8b	US$282.86	15.2	59.4%	n/a
A	US$139.74	2.7%	16.1%	US$37.7b	US$159.32	27.9	12.0%	0.7%
WAT	US$382.41	1.1%	28.1%	US$36.4b	US$413.13	83.5	25.3%	n/a
ALNY	US$268.74	0.5%	-18.3%	US$35.9b	US$432.04	66.7	28.6%	n/a
ONC	US$326.77	2.9%	10.2%	US$35.6b	US$415.20	70.8	30.2%	n/a
TEVA	US$31.18	-3.2%	90.9%	US$35.1b	US$40.90	23.2	16.8%	0%
RPRX	US$59.02	0.8%	61.3%	US$33.8b	US$59.89	31.7	38.6%	1.6%
IQV	US$207.32	-1.5%	3.2%	US$33.1b	US$232.00	25.0	13.1%	n/a
ZTS	US$74.57	-3.0%	-51.2%	US$31.1b	US$113.82	11.7	5.2%	2.8%
BIIB	US$200.62	-2.6%	52.5%	US$29.6b	US$227.59	21.6	13.3%	n/a
ILMN	US$196.86	3.5%	82.9%	US$28.9b	US$172.53	34.9	10.1%	n/a

Page 1 of 30